up and down three times: 29.6 s (SD 12.5 s) and walking 50 m: 34.4 s (SD 8.7 s); standing balance showed a total mean for all three groups of average angular velocity: 1.3 m · s -1 (SD 0.3 m · s -1 ), per cent maximum stability: 65.3 (SD 10.9) and per cent ankle strategy: 70.4 (SD 10.3); isometric muscle strength showed a total mean for all three groups of knee extension: 72.3 Nm (SD 25.6 Nm) and knee flexion: 37.5 Nm (SD 12.6 Nm). Conclusions: Preliminary results indicates that WBV may affect the muscle function and balance in patients with knee OA. However, analysis is in progress, and the final results and conclusions will be presented at the congress.
Purpose: Significant risk factors in development of knee osteoarthritis (OA) has shown to be quadriceps weakness, joint instability, and changes in joint loading. Few studies have looked at these risk factors for hip OA. Furthermore, very few studies, have reported biomechanical changes in gait patterns affecting joint loading. There are no studies so far describing both biomechanics during gait (joint loading) and clinical outcomes in hip OA patients. The purpose of this study was to identify biomechanical and clinical characteristics among patients with hip OA. Methods: Fifty patients aged 60.0 (±10.3) years, 32 women and 18 men, with hip pain >3months, activity limitations, and radiographically verified hip OA were included consecutively. Gait analysis was performed using Qualisys Pro reflex 3D motion analysis system, including three forceplates (AMTI). Furthermore, the disease specific questionnaire,WOMAC, isokinetic muscle strength (TechnoRev9000), sub-maximal cardiovascular function (Åstrand's bike-test), hip range of motion, and 6 minute walk test, the generic health-related quality of life questionnaire (SF-36v2), self-efficacy for pain, and the physical activity scale for the elderly, PASE, were included. Results: The WOMAC showed a mean total score of 25.9 (±15.4) mm, 26.9 (±17.3) mm for pain, 34.4 (±21.5) mm for stiffness, and 24.6 (±15.7) mm for physical function subscales. There was a significant decrease in peak isokinetic muscle strength for the involved versus the uninvolved side for: hipextension 142.2 Nm versus 152.9 Nm (p<0.05), knee-extension 104.7 Nm versus 117.4 Nm (p<0.001), knee-flexion 64.1 Nm versus 67.4 Nm (p<0.05), and ankle-plantarflexion 63.3 Nm versus 67.6 Nm (p<0.05). The gait analysis showed biomechanical changes in the involved versus the non-involved hip and knee. Conclusions: The WOMAC showed a clinically acceptable state for pain and physical function among the studied patients, however, the patients showed significantly decreased muscle strength for hip extension, knee extension and flexion, and ankle plantar flexion. Decreased muscle strength is a significant risk factor for the development of knee OA and should therefore be targeted in these subjects. Both a randomized controlled trial, regarding the effect of exercise therapy, and a case-control study, identifying biomechanical and clinical characteristics, are ongoing. This frequency was confirmed in many prior Russian trials and studies, as being key to stimulating the increase in concentration of beta-endorphins in the brain, spinal fluid and blood (SU Patent #1522500). The aim is to prove the possibility of decreasing pain caused by osteoarthritis (OA) by using transcranial electrostimulation (TES) via the "NEXALIN" device.
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Methods:
The study was multi-centered, randomized, doubleblind, and placebo-controlled. The study population consisted of 211 patients who had been diagnosed with OA of knee and/or hip, had a pain history of at least three months, and scored 4 or more on the Visual Score for Pain Assessment. The "NEXALIN" groups received 7 daily TES session of 40 minutes, 15 mA (root mean square); the placebo group received no stimulation using a visually identical device. Assessment methods: pain level (PL), patient global self-assessment (PGA), walking test (WT), physician's assessment (PA) -all utilizing visual scales. Assessments were performed prior to treatment, during the treatment series, and at the 1 year follow-up assessment. Results: After 7 treatments: PL decreased in the "NEXALIN" group 57%, placebo 24% (p<10-9), WT 54% and 30% (P<10-4); PGA and PA increased respectively 47% and 25% (P<0.04), 44% and 32% (P<0.03). After 2 weeks: PL decreased in the "NEXALIN" group 40%, placebo 21% (p<10-4), WT 42% and 30% (P<0.01); PGA and PA increased respectively 29% and 25% (P<0.66), 42% and 30%(P<0.01). Statically analysis also showed decreasing of PL in the "NEX-ALIN" group during at least 6 weeks. The number and type of side effects were equivalent in both groups, with quantities in placebo exceeding active. Conclusions: "NEXALIN's" TES device, realized through activation of BES, provides significant and prolonged decrease in pain associated with OA, In the multivariate regression models, AA's more likely than whites to be referred to rheumatology (adjusted odds ratio = 1.41, 95% CI was 0.91 to 2.20) and less likely to be referred to orthopedic surgery (adjusted odds ratio = 0.85, 95% CI was 0.57 to1.29), but these differences did not reach statistical significance. Factors that were associated with decreased likelihood of referral to orthopedic surgery included status as currently or ever receiving disability payments due to knee/hip pain (adjusted odds ratio = 0.39, 95% CI was 0.24 to 0.63); and low preference for joint replacement surgery (either willing or not sure) (adjusted odds ratio = 0.58, 95% CI was 0.39 to 0.86). Conclusions: Among patients with chronic knee/hip pain, race is not associated with referral to either rheumatology or orthopedic surgery. However, patient preference for joint replacement and disability were associated with the likelihood of referral to orthopedic surgery. Patient preferences regarding orthopedic procedures should guide interventions designed to address racial disparities in joint replacement utilization.
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P354 ORIGIN OF OSTEOARTHRITIC KNEE PAIN: IMMUNOHISTOCHEMICAL ANALYSIS OF SUBCHONDRAL BONE
S. Ogino, T. Sasho, K. Nakagawa, N. Ochiai, H. Moriya Graduate School of Medicine, Chiba University, Chiba, Japan
Purpose: Osteoarthritis of the knee joint (OA) is the most common form of joint disease. But a mechanism of OA knee pain is poorly understood. OA knee pain has been thought to originate from deformation of periarticular tissues and secondary synovitis. Several authors have reported that pain in the joint mainly caused by free nerve endings which existed in the capsule or synovium. Subchondral bone (SB) that obviously changes histologically as OA progresses appeared to have been neglected as a source of pain. We direct our attention to the pathological change of SB observed in OA knees to see it can be a source of pain. Methods: Medial-type OA knees that received total knee arthroplasty (TKA) in our institution from April 2000 to March 2005 were involved in the present study. Their age, gender, X-ray grading, and knee functional score employing Japanese Orthopedic Association score (JOA score) were recorded at the time of TKA. All patients were underwent X-ray and MR imaging of the affected knees. At the time of TKA, weight-bearing area of medial and lateral femoral condyles (MFC and LFC) was obtained. They were stained with HE solution. Next, immunohistochemical examinations were performed using anti-cyclooxygenase 2 (Cox-2), anti-tumor necrosis factor-α (TNF-α), anti-substance P (SP) and neural class 3 beta-tubulin (TUJ1). The localization of the antigens was visualized by peroxidase-labeled strpt-avidin-biotin staining kit. LFC, that were unaffected compartment, were used as control. The numbers of cysts that evaded SB were counted and cell population forming those cysts were analyzed. Results: Two were male and 21 were female with ages ranging from 62 to 79 years (mean 67.7 years old). No significant difference about cell population in cystic lesions was found between MFC and LFC. Immunohistochemical examination revealed that certain cells in cystic lesions in SB observed in MFC were positively stained with Cox-2, TNF-alpha, TUJ-1 and SP. All specimens were positive for Cox-2 as well as for TUJ1, 91.3% for TNF-α, and 67% for SP. Although more or less cysts with the same kinds of cell composition were found in LFC, no cell was positive for these antigens.
Conclusions:
In the present study, we found that numbers of cystic lesions per unit area in MFC were about five times larger than that of LFC, and no significant difference about cell composition was found in cystic changes between MFC and LFC. Cystic changes observed both in MFC and LFC might be related to bone remodeling. But, considering that TNF-a, Cox-2, TUJ1, and SP were only positive for MFC, character of cysts were totally different between MFC and LFC. Especially, existence of SP and TUJ-1 positive cells in cystic lesions of MFC is direct evidence that SB is pain generator. SP is particularly suggested as one of the most important neuropeptides in the modulation of the inflammatory process of arthritis. Existence of TUJ1 indicates the existence of neural fibers. So the existence of this pain-related molecule in certain cells in cystic lesions along with neural fibers strongly supports our assumption that SB is one of the sources of OA knee pain.
